(Report ID: 84021) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,594 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 289 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 84021 | Mar, 27, 2006 | 90 | Male |
List of drugs the patient takes:
| Name |
Cardiac Failure |
Eosinophilia |
Results from eHealthMe: 289 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Cardiac Failure | 7 (2.42%) |
Eosinophilia | 5 (1.73%) |
Death: 2 (3.85% of total reports)
Cancer: 0
| Name | Count (% of total reports) |
1 | Renal Failure Chronic | 7 (13.46%) |
2 | Myocardial Infarction | 6 (11.54%) |
3 | Oedema Peripheral | 4 (7.69%) |
4 | Thrombocytopenic Purpura | 3 (5.77%) |
5 | Eosinophilic Pneumonia | 3 (5.77%) |
6 | Constipation | 3 (5.77%) |
7 | Dyspepsia | 3 (5.77%) |
8 | Overdose | 3 (5.77%) |
9 | Hepatic Function Abnormal | 3 (5.77%) |
10 | Eosinophilia | 3 (5.77%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Aspirin | 9 |
2 | Urso 250 | 8 |
3 | Furosemide | 5 |
4 | Lasix | 5 |
5 | Mobic | 5 |
6 | Benadryl | 5 |
7 | Heparin Sodium | 5 |
8 | Enalapril Maleate | 4 |
9 | Vesicare | 4 |
10 | Pepcid Rpd | 4 |
Death: 7 (2.42% of total reports)
Cancer: 2 (0.69% of total reports)
| Name | Count (% of total reports) |
1 | Hepatic Function Abnormal | 21 (7.27%) |
2 | Renal Failure Acute | 14 (4.84%) |
3 | Malaise | 14 (4.84%) |
4 | Liver Disorder | 13 (4.50%) |
5 | Anorexia | 12 (4.15%) |
6 | Renal Failure Chronic | 12 (4.15%) |
7 | Hypertension | 11 (3.81%) |
8 | Blood Pressure Increased | 11 (3.81%) |
9 | Condition Aggravated | 11 (3.81%) |
10 | Pyrexia | 10 (3.46%) |
| Name | Count |
1 | Aspirin | 55 |
2 | Lasix | 43 |
3 | Amaryl | 25 |
4 | Aldactone | 22 |
5 | Allopurinol | 20 |
6 | Norvasc | 19 |
7 | Atenolol | 19 |
8 | Furosemide | 19 |
9 | Ramipril | 16 |
10 | Doxazosin Mesylate | 16 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
